Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD refers skin care claims to FDA

This article was originally published in The Tan Sheet

Executive Summary

National Advertising Division finds Pinnacle Marketing has "failed to provide any substantiating information" for its Acadia Skin Care product and has thus referred the case to FDA. In an upcoming NAD Case Report, Council of Better Business Bureaus division challenges print ads claiming Acadia "will help relieve the irritation and embarrassment of psoriasis, eczema, seborrheic dermatitis, rough, dry skin and dandruff," and that product's "active ingredients are FDA approved." In response, Pinnacle maintained claims at issue could be substantiated but said it would not do so "for economic reasons"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS094680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel